Alliance Member Meetings

All employees of Research!America members are eligible to join alliance member meetings. If your organization is not a Research!America member and you’re interested in more information about the alliance, email Katie Goode at

Upcoming Meetings

Research!America Alliance Member Meeting with Pete Kirkham

Date: Wednesday, October 28, 2020; 1:00 p.m. ET

This member meeting will focus on the 2020 election outlook. Register here.

Past Meetings

Research!America Alliance Member Call on BRAIN Initiative

Date: Wednesday, October 21, 2020; 1:00 p.m. ET

NINDS Director Dr. Walter Koroshetz, BRAIN Initiative Director Dr. John Ngai, Chief of the Scientific and Public Engagement Branch in the Office of Neuroscience Communications and Engagement (ONCE) Dr. Samantha White who provided an update on this Initiative and relevant issues such as neuroethics.

Listen to the recording here.


Research!America Alliance Member Call on with Anna Fine and Becky Williams

Date: Thursday, October 15, 2020; 2:30 p.m. ET

Guest speakers Rebecca Williams, PharmD, MPH, acting director of at the National Library of Medicine, National Institutes of Health and Anna Fine, PharmD, Deputy Director at NLM detailed the role is playing in COVID-19 information-sharing and the status of a major modernization project in which Research!America has been participating. Access the summary report of the modernization comments hereWatch the recording here.


Research!America Alliance Member Call with Dr. Lou Garrison and Dr. Andras Incze

Date: Tuesday, October 6, 2020; 11:00 a.m. ET

Dr. Lou Garrison, Professor Emeritus, Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington and Dr. András Incze, founder and CEO of Akceso Advisors, discussed the International Reference Pricing (IRP) model as it relates to a recent Executive Order on drug costs. Dr. Garrison and Dr. Incze emphasized that the E.O. could have long-term negative impacts on R&D and access to treatments worldwide. As an alternative, Drs. Garrison and Incze outlined how a value-based approach - one in which price is tied to the value of a therapy's health outcomes - could function to address affordability while supporting innovation. For a copy of the slides presented, please contact Dr. Lou Garrison at

Research!America Alliance Member Call about Injury Prevention Research

Date: Thursday, October 1, 2020; 1:30 p.m. ET

Dr. Ross McKinney Jr., Chief Scientific Officer, AAMC moderated a panel discussion with esteemed panelists Dr. Rebecca Cunningham, Director, Injury Prevention Center at the University of Michigan, Dr. Stephen Hargarten, MPH, Professor of Emergency Medicine and Associate Dean of Global Health at the Medical College of Wisconsin, Dr. Therese S. Richmond, Andrea B. Laporte Professor of Nursing at the University of Pennsylvania, and Dr. Frederick P. Rivara, Seattle Children's Guild Association Endowed Chair in Pediatric Research at the University of Washington, on what is new in injury prevention research and what is needed to move the needle on firearms violence research.

You can view the full recording here. 

Research!America Alliance Member Call with Dr. Larry Tabak

Date: Wednesday, September 30, 2020; 2:30 p.m. ET

Dr. Larry Tabak, Principal Deputy Director of the National Institutes of Health, discussed how NIH is addressing the current funding situation due to COVID-19 and the outlook for FY2021 grants. Dr. Tabak stressed the continued flexibility of NIH regarding the needs of extramural researchers. The extramural staff at NIH have worked diligently to switch to remote operations, and processes like peer review and the application process have continued to be successful. In some areas, like peer review, the remote model may even be continued beyond the pandemic.  Regarding the flexibility of the Institutes/Centers (ICs), many are considering extensions on a grant-by-grant basis, recognizing that researchers face unique challenges during this time. Overall, flexibility has and will continue to be key for all parties. In October, a survey will be sent to extramural organizers/researchers and feedback is greatly appreciated. 

View the recording here.

Research!America Alliance Member Call with Dr. Eliseo Pérez-Stable

Date: Monday, July 27, 2020, 2:30 p.m. - 3 p.m. ET

Eliseo J. Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH), discussed that the groups of his institute’s focus -- racial and ethnic minorities, those from low socio-economic status, underserved rural residents, and sexual and gender minorities -- have a shorter life expectancy than other Americans. COVID-19 has spotlighted this dramatically.

Access his recent opinion piece on this in JAMA. Dr. Pérez-Stable also discussed funding opportunities for scientists -- of particular interest for those working alongside NIMHD-- through NIH’s Rapid Acceleration of Diagnostics (RADx) initiative. 

The full recording and slides are here.


Research!America Alliance Member Meeting with Dr. Judith Salerno

Date: Thursday, July 23, 2020, 1:30 p.m. - 2 p.m. ET

Judith A. Salerno, MD, MS, President of The New York Academy of Medicine, shared her experience returning to clinical work at Bellevue Hospital during the height of the COVID-19 crisis in New York City. Dr. Salerno joined the palliative care unit, connecting families with loved ones in the ICU, which was logistically difficult given that most of her patients were intubated, and family members could not visit in person. When Dr. Salerno arrived at Bellevue, there were seven ICUs full of intubated COVID-19 patients. The vast majority were people of color, and about half of Dr. Salerno’s patients’ families did not speak English, so she had to speak through a translator. Many of the patients had worked in environments like kitchens or construction sites and lived in apartments with many other people. Some delayed seeking care because they did not know they were entitled to care no matter their legal status; others had to keep working because they needed the money.

Dr. Salerno also discussed the severe PPE shortage. On her first day, Dr. Salerno received just one N95 mask to use, though she eventually accumulated five masks that she rotated through -- one for each day of the week. Dr. Salerno noted that she saw many unanticipated symptoms given that doctors thought COVID-19 was an acute respiratory syndrome; these included kidney failure, strokes, and clotting such that limbs required amputation. Dr. Salerno and her colleagues also saw guidance shifting early on because there was no clear understanding of best practices at the beginning of the pandemic. Now, Dr. Salerno says, there is much clearer guidance, like using anticoagulants, acquiring dialysis machines, and implementing new treatment regimens.

Dr. Salerno also noted that she is very concerned about emotional trauma in health workers, particularly young medical professionals. She spoke about the nightmares that workers experienced and of walking two miles home every day just to decompress. While there are mental health resources in place now, Dr. Salerno predicts that the fallout from this crisis will be long-lasting. Finally, Dr. Salerno emphasized that advocates must relentlessly press for vaccination awareness and future funding.


Research!America Alliance Member Meeting with Dr. Gary Gibbons

Date: Monday, July 13, 2020, 1 p.m. - 1:30 p.m.

Gary Gibbons, MD, Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) discussed NHLBI's COVID-19 response given the significance of heart and lung conditions, racial and ethnic disparities in the pandemic’s impact, and the effect of COVID-19 on research outside the pandemic’s sphere. Dr. Gibbons explained how COVID-19 is affecting many of the organ systems under the umbrella of NHLBI. The institute is working to understand the pathophysiology of COVID-19, test new treatments, promote blood safety, and test behavioral, social and community-based interventions. Dr. Gibbons also explained that COVID-19 seems to specifically affect the blood, leading to blood clots which can damage the heart and lungs. Dr. Gibbons has high hopes for serum treatment from recovered patients being used to prevent the disease from worsening in other patients. NHLBI has also launched a collaboration called connect, which does just that among different clinical trial sectors within the NHLBI. Dr. Gibbons also touched on Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 and how NHBLI is investigating this disease. See the recording here.


Research!America Alliance Member Meeting with Dr. Chris Austin

Date: Thursday, July 9, 2020, 4 p.m. - 4:30 p.m.

Chris Austin, MD, Director of the National Center for Advancing Translational Sciences at the National Institutes of Health joined us to talk about NCATS's new Open Data Portal, National COVID Cohort Collaborative and other NCATS priorities. Also on the live video call was Dr. Joni Rutter, Deputy Director of NCATS, who discussed the current open science initiatives at NCATS in the context of COVID-19. The National COVID Cohort Collaborative (N3C) is a centralized, secure platform to store and study data. The goal is to collect and harmonize up to 1-2 million U.S. clinical health records. Then, collaborative analytics will be performed to develop treatments and answer questions like “Can we predict who might have severe outcomes?”

Another initiative, SARS-CoV-2 OpenData, is speeding the identification of drugs for COVID-19 by sharing results and methods from ongoing research of drug repurposing. The idea is to run as many experiments as possible across all drugs and to make the data immediately available to the world. 

Finally, CURE ID is a mobile app created from a collaboration between NCATS and the FDA. The app allows health care workers to share their clinical experience using approved drugs to treat diseases other than the one they were originally intended for.

See the recorded meeting here.


Research!America Alliance Member Webinar with Rep. Tom Cole (R-OK)

Date: Tuesday, July 7, 2020, 11:30 a.m. ET

Featuring: Congressman Tom Cole

Research!America members met virtually with Congressman Tom Cole, the ranking member of the Labor-H subcommittee. Rep. Cole explained that Congress is working on both the appropriation markups and another supplemental bill. Congressman Cole expects that the supplemental will be completed by late July or early August. It will include financing for personal assistance, NIH, state and tribal assistance, and school and daycare funding. The congressman expressed the need for Congress to set aside emergency money and to build up the CDC’s infrastructure to prepare for a future crisis. Equating COVID-19 to a “biomedical Pearl Harbor,” Rep. Cole emphasized that we “need to spend billions to save trillions” and prioritize strengthening our public health system and research enterprise during this appropriations season. Overall, Rep. Cole thinks that NIH will receive increased funding but that in the next year they may see a dip in funding since most of this year’s funding is coming from supplements.


Research!America Alliance Member Webinar with Dr. Tom Frieden

Date: Monday, June 29, 2020, 1:30 p.m. ET

Featuring: Dr. Tom Frieden, CEO, Resolve to Save Lives

Former CDC Director Tom Frieden, MD, President and CEO of Resolve to Save Lives, an initiative of Vital Strategies, joined alliance members to discuss a proposal he and other public health leaders have developed to expedite the resources needed when pandemics and other national public health emergencies arise. Dr. Frieden advocated for a balanced portfolio of research that spans basic to operational across a range of agencies, to achieve the maximum possible health benefit. He argued that research should not just be led by the NIH -- it should include the FDA, CDC, BARDA, HHS, and Department of Agriculture. Dr. Frieden stated that the federal government has not stepped up to lead during this emergency, emphasizing that public health must guide us forward. He advocated for sustained support for public health through funding and public messaging, disease surveillance, more nuanced reopening strategies, and use of the “Box-it-in” approach, which includes widespread testing, contact tracing, isolating infected people, and quarantine periods. Dr. Frieden mentioned a resource for state-level data:, which was created by Resolve to Save Lives.

If you are a Research!America alliance member, click here to see the recording.


Research!America Alliance Member Webinar with Dr. Nora Volkow

Date: Wednesday, June 24, 2020, 1 p.m. ET

Featuring: Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at NIH and Patrick J. Kennedy, Former U.S. Representative (D – RI) and Founder of the Kennedy Forum. 

Dr. Volkow discussed the Institute’s COVID-19 response and the precarious intersection between the pandemic, individuals with substance use disorders, and substance misuse. Dr. Volkow began the meeting by describing the landscape of COVID-19 and drug use. Dr. Volkow explained that taking drugs negatively impacts the lungs, metabolism, and heart, increasing the chances of a complication for a patient with COVID-19. While access to addiction treatment is still woefully insufficient, COVID-19 has changed some regulations regarding telehealth. Doctors can now prescribe addiction medication via telehealth and patients are allowed to take methadone at home for one month at a time. Dr. Volkow ended her segment by talking about NIDA’s supplemental initiative to garner research about COVID-19 as it relates to HIV or hepatitis C treatments. 

After hearing from Dr. Volkow, The Honorable Patrick J. Kennedy spoke about his experience on Capitol Hill striving for more inclusive mental health reform. He applauded NIDA for emphasizing service related research. Mr. Kennedy explained that depression needs to have it’s own agency, similar to NCI or NIDA and that we will need a “Moon Shot” to make vast improvements for depression treatment and regulations. Mr. Kennedy also expressed the need for mental health services to be reimbursable by insurance companies.

If you are an alliance member, click here to see the recording.

Immigration Update with Scott Corley and Michael Maloney

Date: Monday, June 22, 2020, 2:00 p.m. - 2:45 p.m. 

Featuring: Scott Corley, President of Corley Consulting and Michael Moloney, CEO of the American Institute of Physics. 

Scott Corley of Corley Consulting gave a state of play for current and upcoming executive actions regarding immigration and researchers. President Trump was expected to sign an executive order on June 22, under the executive 212(f) authority that will suspend the following immigration programs days with very few exclusions: H1B, L1 (except for L1-A, which includes intracompany transferees who work in managerial or executive positions in a company located outside of the U.S.), and J visas (J-1 is for individuals approved to participate in work-and study-based exchange visitor programs, and J-2 is for the spouse and/or children of J-1 recipients). However, this will only impact new visas, not visa renewal, and the elimination of the Optional Practical Training (OPT) will not be included in the executive order. 
Michael Moloney, PhD, of the American Institute of Physics led a discussion of the steps members could take in the advocacy space. Currently, a petition created by Dr. Ushma Neill of Memorial Sloan Kettering Cancer Center has gathered almost 10,000 signatures. Several organizations, including American Association for Dental Research, and APS, are also involving their own members, particularly students who have experience with these programs; they are leading Twitter and letter writing campaigns directed at members of Congress. Dr. Moloney also highlighted NAFSA as a resource for data to support advocacy.


Research!America Alliance Member Webinar with Dr. Jeff Allen

Date: Friday, June 19, 2020, 12 p.m. ET

Featuring: Dr. Jeff Allen, President and CEO of Friends of Cancer Research

This alliance call hosted Jeff Allen, president and CEO of Friends of Cancer Research (Friends). Dr. Allen spoke about the halted clinical trials and the long term impacts of COVID-19 on clinical research. Though COVID-19 has stalled trials, limited patient access to treatment, and plummeted preventive screenings, there have been a few silver linings. These include expediting IRB reviews, preplanned modifications and amendments, utilization of master protocols, and the adoption of remote services such as telehealth and prescription delivery. Friends has partnered with the Regan-Udall Foundation to develop the COVID-19 Evidence Accelerator. The goal of the accelerator is to leverage real-world data to learn about the COVID-19 crisis and how effective therapeutics, diagnostics, and vaccines are and will be. The accelerator uses tools such as prioritized research questions, common data elements, and common protocols to facilitate the combination of real world data from many collaborative sources. Dr. Allen stated that the goal is to generate open communication and speed the process of data collection and analysis.
If you are an alliance member, click here to view the recording.


Research!America Alliance Member Webinar with Dr. Kelvin Droegemeier

Date: Thursday, June 11, 2020, 1 p.m. ET

Featuring: Dr. Kelvin Droegemeier, Director of the Office of Science and Technology Policy, The White House

Dr. Droegemeier anticipates the administration releasing its R&D priorities memo in July, and that education will figure prominently. He welcomed suggestions for reinvigorating the research enterprise as it reopens. In closing, he said, “The research enterprise is the future of our country. Science has a special moment right now; we can’t take our foot off the gas.”



Research!America Alliance Member Webinar with Dr. Josh Gordon

Date: June 1, 2020, 1 p.m. ET

Featuring: Dr. Josh Gordon, Director of the National Institute of Mental Health (NIMH)

Dr. Gordon discussed the Institute’s work about NIMH's COVID-19 response and the critical intersection between the pandemic and mental health. He explained that the global impact, social isolation, and the length of the crisis will affect people’s mental health and require innovative solutions. While many NIMH clinical trials have been stalled due to COVID-19, new survey and telehealth trials have begun to obtain the best possible understanding of how this crisis is affecting patient populations. Dr. Gordon further explained that NIMH has opened and will open more supplementary opportunities for extramural researchers to investigate the impact of COVID-19 on mental health and possible solutions.

If you are an alliance member, click here to view the recording.


Research!America Alliance Member Webinar with Dr. Carolyn Clancy and Dr. Rachel Ramoni

Date: May 29, 2020, 2 p.m. ET

Featuring: Dr. Carolyn Clancy, Deputy Under Secretary for Discovery, Education and Affiliate Networks (10X), Veterans Health Administration; Dr. Rachel Ramoni, Chief Research and Development Officer (10P9), Veterans Health Administration

This alliance call hosted two members of the Veterans Health Administration; Dr. Carolyn Clancy, the Deputy Secretary for Discovery, Education and Affiliate Network, and Dr. Rachel Ramoni, Chief Research and Development officer. Dr. Clancy began the discussion by demonstrating the breadth and funding of the Veteran’s Association. Dr. Ramoni then spoke about the VA’s overarching strategic principles and the valuable clinical trials structure which has allowed the VA to quickly adapt during the COVID-19 pandemic. The VA is uniquely positioned to contribute to research. During the COVID-19 crisis, the VA has expanded access for the Mayo Clinic convalescent-plasma protocol at more that 80 VA medical clinics, conducted the HITCH clinical trial which is testing a prostate cancer drug, degarelix, as a COVID-19 treatment, conducted the Epidemiology, Immunology, and Clinical Characteristics of COVID-19 (EPIC3) “natural history” observational study with DOD, assisted in NIAID-sponsored trials of remdesivir and baricitinib, and worked with big data and informatics. During the question portion of the meeting, Dr. Clancy explained that the VA is making strong progress in telehealth. For a recap of this discussion, click here.


Research!America Alliance Member Webinar with U.S. Representative Don Beyer (D-VA-8)

Date: Thursday, May 28, 3 p.m. ET

An alliance member call with U.S. Representative Don Beyer, (D-VA-8) to discuss current priorities and recent AHRQ proposals.





Research!America Alliance Member Webinar with Dr. Victor Dzau

Date: May 22, 2020, 1 p.m. ET

Featuring: Dr. Victor Dzau, President of the National Academy of Medicine

Dr. Dzau discussed the NAM's work related to COVID-19, main issues in what it will take to effectively respond to the pandemic, and what might change in how we respond to future outbreaks. Dr. Dzau started the conversation with an impressive overview of the National Academy of Medicine’s response to COVID19. He explained that an expert committee has completed 11 expert consultations on topics ranging from virus shedding to the effectiveness of fabric masks. Dr. Dzau also stressed the importance of innovation and technology.

If you are an alliance member, click here to view the recording.

Research!America Alliance Member Webinar with the Honorable Louis W. Sullivan

Date: May 11, 2020

Featuring: Dr. Louis Sullivan, former Secretary, Health and Human Services, and Chairman, Sullivan Alliance to Transform the Health Professions.

Dr. Sullivan spoke about the importance of biomedical research and how it has improved human health. In 1989, Dr. Sullivan was on the front lines of the HIV/AIDS crisis as secretary of HHS under the Bush administration. Today, HIV/AIDS patients live longer and healthier lives because of biomedical innovation. Dr. Sullivan explained that examples of research leading to treatments and vaccines, such as HIV/AIDS, smallpox, and polio, can be used to show the public the importance of biomedical research. Now, in the current pandemic, biomedical research must continue to be a high priority. Dr. Sullivan also discussed the African American, Latino, and Indigenous populations which are disproportionately affected by COVID-19. Minorities have higher infection rates and hospitalization rates and are more likely to die from COVID-19 than non-minorities. Dr. Sullivan explained that this is because more minorities work in service jobs, minorities have a history of distrusting medical professionals, and are more likely to have underlying conditions such as heart disease and obesity which make patients more susceptible to COVID-19. Dr. Sullivan finished his remarks by stating that investing in health is an investment in a better future. 

You can view the recording here.

Research!America Alliance Member Call with Dr. Peter Hotez

Date: May 6, 2020

Featuring: Dr. Peter HotezDean of the Baylor School of Medicine National School of Tropical Medicine

Dr. Peter Hotez spoke about the history of vaccines, COVID-19 vaccine development, and the spread of the novel coronavirus across the southern hemisphere. He also spoke about the anti-science and anti-vaccine movements in our country and globally.

You can watch the meeting here and you can view his slides here.


Research!America Alliance Member Call with Dr. Francis Collins and Dr. Keith Yamamoto

Date: April 30, 2020

Featuring: Dr. Francis CollinsDirector, National Institutes of HealthDr. Keith YamamotoProfessor Emeritus; Vice Chancellor for Science Policy and Strategy; Director, UCSF Precision Medicine, University of California, San Francisco

Dr. Collins provided an overview of NIH’s unprecedented Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)(link is external) and the Rapid Acceleration of Diagnostics (RADx) Initiative(link is external). Dr. Yamamoto discussed the impact of COVID-19 on the research ecosystem and highlighted some of the collaborations taking place to respond to the pandemic. Listen to the recording here

Research!America Alliance Member Call with Donna Cryer

Date: April 28, 2020

Featuring: Donna CryerPresident and CEO of the Global Liver Institute; Leslie RitterAssociate Vice President, Federal Government Relations at National MS Society

Donna shared updates on her organization's comprehensive COVID-19 response program. Leslie discussed the disruptive impact of COVID-19 on research supported by voluntary health associations, philanthropies and scientific societies.

For a recording of the call, click here.


Research!America Alliance Member Call with Dr. Harvey V. Fineberg

Date: April 20, 2020

Featuring: Dr. Harvey V. FinebergPresident of the Gordon and Betty Moore Foundation and chair of the National Academies Standing Committee on Emerging Infectious Diseases

Dr. Harvey V. Fineberg discussed the steps needed to contain and ultimately end the COVID-19 pandemic.

For a recording of the call, click here.


Research!America Alliance Member Call with Dr. Rick Bright and Scott Whitaker

Date: April 15, 2020

Featuring: Dr. Rick BrightDeputy Assistant Secretary for Preparedness and Response and Director of the Biomedical Advanced Research and Development Authority (BARDA); Scott Whitaker, President and CEO of AdvaMed

Scott Whitaker discussed how the medical device and diagnostic sectors are working on to combat the pandemic. Dr. Rick Bright provided an update on BARDA's COVID-19 efforts. 

You can find a link to this terrific conversation here.


Research!America Alliance Member Call with Dr. Robert Redfield

Date: April 13, 2020

Featuring: Dr. Robert Redfield, Director of the Centers for Disease Control and Prevention (CDC)

Research!America hosted a conference call for our members and partners on April 13, 2020, with Dr. Robert Redfield who provided an overview of the COVID-19 pandemic and the CDC’s response.

There is no recording available for this call. Access highlights from the call here.


Research!America Alliance Member Call with Adrienne Hallett

Date: April 9, 2020

Featuring: Adrienne Hallett, Director of the NIH Office for Legislative Policy and Analysis

Research!America hosted a conference call for our members and partners on April 9, 2020 with Adrienne Hallett who shared updates on NIH COVID-19 response efforts.

There is no recording available for this call. 


Research!America Alliance Member Call with Dr. Georges Benjamin

Date: April 7, 2020

Featuring: Dr. Georges Benjamin, Executive Director of APHA

Research!America hosted a call on April 7, 2020, with Research!America board member and APHA Executive Director Dr. Georges Benjamin, discussing the nationwide response to COVID-19 and National Public Health Week. 

Access Dr. Benjamin’s presentation here.


Research!America Alliance Member Call with Rear Admiral Erica Schwartz and Emily Holubowich

Date: March 30, 2020

Featuring: Rear Admiral Erica SchwartzDeputy Surgeon General; Emily Holubowich, Vice President of Federal Advocacy of the American Heart Association

The Research!America Alliance Member Call on March 30, 2020, featured Deputy Surgeon General RADM Erica Schwartz who spoke about frontline COVID-19 testing and protecting our first responders. Emily Holubowich wrapped up the second half of the call by providing an FY21 appropriations state-of-play.

There is no recording available of this call.

Research!America Alliance Member Call with Dr. Skorton

Date: March 24, 2020

Featuring: Dr. David SkortonPresident of the Association of American Medical Colleges

Research!America hosted a call on March 24, 2020, with Dr. David Skorton on strategies for academic health centers during the COVID-19 pandemic. In a content-filled, motivating conversation, Dr. Skorton and his colleagues emphasized the irreplaceable value of fundamental research and the critical importance of public-private partnerships. 

You can find a link to this terrific conversation, including alliance member Q&A, here.


Research!America Alliance Member Call with Dr. Jacqueline Corrigan Curay and Dana Acton

Date: March 19, 2020

Featuring: Dana ActonLegislative Director for House Appropriations Chairwoman Nita Lowey (D-NY-17); Dr. Jacqueline Corrigan-Curay, Director of the Office of Medical Policy at FDA’s Center for Drug Evaluation and Research (CDER) 

Dr. Jacqueline Corrigan-Curay provided an update on FDA’s implementation of the 21st Century Cures Act and Dana Acton discussed FY21 appropriations and supplemental COVID-19 funding.

There is no recording available of this call.

Research!America Alliance Member Call with Dr. Larry Tabak and Dr. Michael Lauer

Date: March 16, 2020

Featuring: Dr. Larry TabakPrincipal Deputy Director of the National Institutes of HealthDr. Michael LauerDeputy Director for Extramural Research at the National Institutes of Health

Dr. Tabak and Dr. Lauer discussed NIH’s efforts to ensure research institutions and scientists are accorded the flexibility needed as they confront COVID-19-related research disruptions. 

A recording of the detail-rich call can be accessed here.


Media Contacts

Robert Shalett
Director of Communications 

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana